
New transaction for Laboratoire XO
Health, Laboratoire X.O
Paris, October 29, 2021 - Laboratoire X.O has entered into a transaction with Astellas Pharma Inc. for the rights to nicardipine (3 brands) in 4 European countries. This will strengthen our portfolio of 24 brands and our European footprint.
Since…

Laboratoire XO celebrates its 5th anniversary
Health, Laboratoire X.O
Laboratoire X.O is a French success story.
Our objective? To provide patients and healthcare professionals with innovative, qualitative products of real therapeutic interest.
The story began in 2015 with the acquisition of 2 brands identified…

Laboratoire XO launches its brand new mouthwash
Health, Laboratoire X.O
As part of the extension of Laboratoire X.O's range of OTC products, a new range of cosmetic mouthwashes with disruptive flavours has been launched: Prexifresh Mango & Mint.
This is a daily treatment whose objective is to reduce the…

1 in 2 women suffer from painful periods…
Health, Laboratoire X.O
1 femme sur 2 souffre de règles douloureuses...
According to a study carried out on a representative sample of patients from the Social Security Health Examination Centres, 49% of non-menopausal women suffer from pain during their periods.
Dysmenorrhoea…